NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.
Cohance Lifesciences Ltd: key numbers
- Share price
- ₹440.35
- Market cap
- ₹16,848 Cr
- Revenue (annual)
- ₹2,269 Cr
- Net profit (annual)
- ₹179.2 Cr
- P/E (TTM)
- 158.6×Sector 41.3×
- Promoter holding
- 57.48%-0.01% QoQ
- FII holding
- 7.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cohance Lifesciences Ltd
All →Cohance Lifesciences Board Meeting Date
Cohance Lifesciences will hold a board meeting on 6 November 2026 to approve Q2 and half-year results. The trading window stays closed until 9 November 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), disclosing promoter and public shareholding data as of September 30, 2026.
Cohance Lifesciences Regulatory Approval
Cohance Lifesciences received Central Government approval for the appointment of Mr. Umang Vohra as Chairman and Group CEO.
Cohance Lifesciences Employee Stock Options
Cohance Lifesciences Ltd. approved the grant of 2,60,194 stock options under ESOP 2026 and 6,14,594 stock options under ESOP 2023 to eligible employees.
Cohance Lifesciences Management Change
Cohance Lifesciences appointed Mr. Abhimanyu Ojha as the new Chief Financial Officer and Key Managerial Personnel, effective October 12, 2026.
Cohance Lifesciences Other Announcement
Cohance Lifesciences received a voluntary ESG Rating of Crisil ESG 61 (Strong) from Crisil ESG Ratings. No capital or business event is involved.
Other board meeting outcome announcements
All →Kasturi Metal Composite Board Meeting Outcome
Kasturi Metal Composite's board approved voluntarily publishing quarterly financial results from the quarter ending December 31, 2026. The mandatory SME filings remain half-yearly.
Tanvi Foods (India) Board Meeting Outcome
Tanvi Foods (India) Limited re-appointed Ms. Jonnada Vaghira Kumari as Non-Executive Independent Director for 60 months, effective 3 November 2026. This is a routine board-level director re-appointment.
Jyoti Structures Board Meeting Outcome
Jyoti Structures reconstituted its Nomination and Remuneration Committee and Risk Management Committee after its November 3, 2026 board meeting. The filing lists the revised members and chairpersons only.
Dhampure Specialty Sugars Board Meeting Outcome
Dhampure Speciality Sugars reconstituted its Audit, Nomination & Remuneration and Stakeholders' Relationship Committees effective 3 Nov 2026. No money or business event is involved.
Hardwyn India Board Meeting Outcome
Hardwyn India appointed M/s. Amit H.V. & Associates as the new Secretarial Auditor to fill a casual vacancy for the financial year 2025-2026.
The Orissa Minerals Development Company Board Meeting Outcome
Orissa Minerals Development Company's board approved the Directors' Report and notice for its 108th AGM on 3 November 2026. The filing also notes other agenda items, but none are specified.